Playground →
Bristol Myers Squibb's nearest ten neighbors split almost evenly between two subcategories — Healthcare brands and B2B services firms — with no single neighbor pulling far ahead of the rest.
The shape is flat: scores run from Amgen at 0.96 down to Merck at 0.92, a band of less than four points across all ten. Five neighbors carry the Healthcare subcategory — Amgen (0.96), Novartis (0.96), AstraZeneca (0.94), Johnson & Johnson (0.94), and GSK (0.93) — making Bristol Myers Squibb's own kind the dominant presence in the cluster. The other five are B2B services: Accenture (0.93), IBM Cloud (0.93), IBM Data and AI (0.92), KPMG (0.92), and Merck (0.92). No media brands, no consumer brands, and no individual personalities appear in the top 10 — the cluster is entirely institutional. The B2B presence is notable: consulting and enterprise technology firms draw audiences whose composition resembles a major pharmaceutical company's, despite having no thematic overlap with drug development.
The flat shape, combined with the tight Healthcare-plus-B2B composition, points to an audience defined by professional and institutional orientation rather than any single sector loyalty.
